G.Barekat Pharm (XTEH:BRKT1) Net Income (Continuing Operations) : IRR2,981,026 Mil (TTM As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. G.Barekat Pharm's Net Income (Continuing Operations) for the six months ended in Mar. 2017 was IRR2,981,026 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2017 was IRR2,981,026 Mil.

G.Barekat Pharm Net Income (Continuing Operations) Historical Data

The historical data trend for G.Barekat Pharm's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Net Income (Continuing Operations) Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Net Income (Continuing Operations)

2,300,921.00

2,981,026.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Net Income (Continuing Operations)	2,300,921.00	2,981,026.00

G.Barekat Pharm Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2017 was IRR2,981,026 Mil.

G.Barekat Pharm (XTEH:BRKT1) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

G.Barekat Pharm Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines